TimeScale Financial’s AbbVie ABBV Stock Holding History

TimeScale Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$81.9K	Sell	608 -263	-30%	-$38.6K	0.02%	174
2023 Q1	$139K	Buy	871 +210	+32%	+$32.1K	0.03%	119
2022 Q4	$88.7K	Buy	661 +1	+0.2%	+$153	0.03%	121
2022 Q3	$89K	Buy	660 +63	+11%	+$9.04K	0.03%	119
2022 Q2	$91K	Sell	597 -208	-26%	-$31.8K	0.02%	122
2022 Q1	$131K	Sell	805 -65	-7%	-$9.44K	0.03%	106
2021 Q4	$118K	Buy	870 +7	+0.8%	+$827	0.03%	122
2021 Q3	$93K	Sell	863 -272	-24%	-$31.1K	0.02%	134
2021 Q2	$128K	Buy	1,135 +102	+10%	+$11.5K	0.03%	104
2021 Q1	$112K	Buy	1,033 +7	+0.7%	+$749	0.03%	111
2020 Q4	$110K	Sell	1,026 -91	-8%	-$8.74K	0.03%	103
2020 Q3	$97K	Buy	1,117 +606	+119%	+$57.1K	0.03%	104
2020 Q2	$51K	Buy	511 +31	+6%	+$2.73K	0.02%	146
2020 Q1	$36K	Sell	480 -51	-10%	-$4.34K	0.01%	156
2019 Q4	$47K	Hold	531	–	–	0.01%	182
2019 Q3	$40K	Sell	531 -10	-2%	-$686	0.01%	196
2019 Q2	$39K	Buy	+541	New	+$42.5K	0.01%	204

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TimeScale Financial's ABBV Position: Q2 2023 in Review

TimeScale Financial reduced its AbbVie (ABBV) stake by 30% in Q2 2023, selling an estimated $38.6K and leaving 608 shares worth $81.9K. The position accounts for 0.02% of the portfolio, ranked #174.

TimeScale Financial first reported a position in ABBV in Q2 2019 and has held it in 17 quarters since. The position peaked at $139K in Q1 2023. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

TimeScale Financial held 608 shares of AbbVie worth $81.9K as of Q2 2023.
TimeScale Financial sold 263 AbbVie shares in Q2 2023, an estimated $38.6K.
AbbVie made up 0.02% of TimeScale Financial's portfolio in Q2 2023, its #174 holding.
TimeScale Financial first reported a position in AbbVie in Q2 2019 and has held it in 17 quarters since.
TimeScale Financial's AbbVie position peaked at $139K in Q1 2023.
3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.